136 related articles for article (PubMed ID: 21671136)
1. A new method of producing monoclinic paracetamol suitable for direct compression.
Ogienko AG; Boldyreva EV; Yu Manakov A; Boldyrev VV; Yunoshev AS; Ogienko AA; Myz SA; Ancharov AI; Achkasov AF; Drebushchak TN
Pharm Res; 2011 Dec; 28(12):3116-27. PubMed ID: 21671136
[TBL] [Abstract][Full Text] [Related]
2. Effect of preparation method on compactability of paracetamol granules and agglomerates.
Fichtner F; Rasmuson AC; Alander EM; Alderborn G
Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
[TBL] [Abstract][Full Text] [Related]
3. Compression behavior of orthorhombic paracetamol.
Joiris E; Di Martino P; Berneron C; Guyot-Hermann AM; Guyot JC
Pharm Res; 1998 Jul; 15(7):1122-30. PubMed ID: 9688070
[TBL] [Abstract][Full Text] [Related]
4. Spray-dried cellulose nanofibers as novel tablet excipient.
Kolakovic R; Peltonen L; Laaksonen T; Putkisto K; Laukkanen A; Hirvonen J
AAPS PharmSciTech; 2011 Dec; 12(4):1366-73. PubMed ID: 22005956
[TBL] [Abstract][Full Text] [Related]
5. Crystallo-co-spray drying as a new approach to manufacturing of drug/excipient agglomerates: Impact of processing on the properties of paracetamol and lactose mixtures.
McDonagh AF; Tajber L
Int J Pharm; 2020 Mar; 577():119051. PubMed ID: 31981704
[TBL] [Abstract][Full Text] [Related]
6. Determination of paracetamol in pure and pharmaceutical dosage forms by pulse perturbation technique.
Pejić N; Kolar-Anić L; Anić S; Stanisavljev D
J Pharm Biomed Anal; 2006 May; 41(2):610-5. PubMed ID: 16413730
[TBL] [Abstract][Full Text] [Related]
7. Formation and compression characteristics of prismatic polyhedral and thin plate-like crystals of paracetamol.
Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
Int J Pharm; 1999 Sep; 187(1):77-89. PubMed ID: 10502615
[TBL] [Abstract][Full Text] [Related]
8. Direct compression and moulding properties of co-extruded isomalt/drug mixtures.
Ndindayino F; Vervaet C; Van den Mooter G; Remon JP
Int J Pharm; 2002 Mar; 235(1-2):159-68. PubMed ID: 11879751
[TBL] [Abstract][Full Text] [Related]
9. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
[TBL] [Abstract][Full Text] [Related]
10. An investigation into the effects of thermal history on the crystallisation behaviour of amorphous paracetamol.
Qi S; Avalle P; Saklatvala R; Craig DQ
Eur J Pharm Biopharm; 2008 May; 69(1):364-71. PubMed ID: 18036792
[TBL] [Abstract][Full Text] [Related]
11. Powder Compression Properties of Paracetamol, Paracetamol Hydrochloride, and Paracetamol Cocrystals and Coformers.
Persson AS; Ahmed H; Velaga S; Alderborn G
J Pharm Sci; 2018 Jul; 107(7):1920-1927. PubMed ID: 29614273
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of freeze-dried wafers and solvent evaporated films as potential drug delivery systems to mucosal surfaces.
Boateng JS; Auffret AD; Matthews KH; Humphrey MJ; Stevens HN; Eccleston GM
Int J Pharm; 2010 Apr; 389(1-2):24-31. PubMed ID: 20083177
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical characterization of the orthorhombic polymorph of paracetamol crystallized from solution.
Nichols G; Frampton CS
J Pharm Sci; 1998 Jun; 87(6):684-93. PubMed ID: 9607944
[TBL] [Abstract][Full Text] [Related]
14. Spray-drying as a method for microparticulate controlled release systems preparation: advantages and limits. I. Water-soluble drugs.
Palmieri GF; Bonacucina G; Di Martino P; Martelli S
Drug Dev Ind Pharm; 2001; 27(3):195-204. PubMed ID: 11291199
[TBL] [Abstract][Full Text] [Related]
15. 3D extrusion printing of high drug loading immediate release paracetamol tablets.
Khaled SA; Alexander MR; Wildman RD; Wallace MJ; Sharpe S; Yoo J; Roberts CJ
Int J Pharm; 2018 Mar; 538(1-2):223-230. PubMed ID: 29353082
[TBL] [Abstract][Full Text] [Related]
16. Preparation and crystal structure of a trihydrate of paracetamol.
McGregor PA; Allan DR; Parsons S; Pulham CR
J Pharm Sci; 2002 May; 91(5):1308-11. PubMed ID: 11977106
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of coprocessed disintegrants produced from tapioca starch and mannitol in orally disintegrating paracetamol tablet.
Adeoye O; Alebiowu G
Acta Pol Pharm; 2014; 71(5):803-11. PubMed ID: 25362809
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Matrix Tablets Based on Eudragit®E100/Carbopol®971P Combinations for Controlled Release and Improved Compaction Properties of Water Soluble Model Drug Paracetamol.
Obeidat WM; Nokhodchi A; Alkhatib H
AAPS PharmSciTech; 2015 Oct; 16(5):1169-79. PubMed ID: 25724162
[TBL] [Abstract][Full Text] [Related]
19. Highly compressible paracetamol - II. Compression properties.
Garekani HA; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
Int J Pharm; 2000 Nov; 208(1-2):101-10. PubMed ID: 11064215
[TBL] [Abstract][Full Text] [Related]
20. In vitro drug release studies of polymeric freeze-dried wafers and solvent-cast films using paracetamol as a model soluble drug.
Boateng JS; Matthews KH; Auffret AD; Humphrey MJ; Stevens HN; Eccleston GM
Int J Pharm; 2009 Aug; 378(1-2):66-72. PubMed ID: 19477255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
